today, sarepta came out with phase 2 data on the drug. that was not just good, it was down right incredible. it was supposed to slow or halt the progress of the disease. but in the data we got today, sarepta's drug didn't nearly -- merely halt the progress, it led to improvement in patients' ability to walk, not just slowed deterioration. these results were better than the most bullish of the bulls could have hoped for. the drug has to be approved by the fda. but after this data, it's on an accelerated track for approval. the biggest move i've ever seen in a day. we don't chase here at "mad money." i think this story's highly educational. let's take a closer look with chris garabedian, the president and ceo of sarepta therapeutics. on this tremendous victory lap day for his company. i am thrilled to have mr. garabedian. welcome to "mad money," sir. >> thank you, jim. it's great to be here. >> i've been investing for 31 years. i've never seen a move this large in a single day. and that is because i imagine that this is a drug that no one k

sarep sarepta therapeutics is doubling. it's up a whopping 183%.g a contender for sunshine, it was a home run. talking of home, the home re-fi boom. it's rolling on. a double digit jump last week with homeowners loving those really low record rates, which, by the way, is putting more cash in their pockets. it's also meant to stimulate the economy. that's the whole idea. but are the savings really trickling down to help everyone, like people in construction and home improvement? we have the co-owner of the largest independent hardware store joining us on the cnbc news line. his name is howard miller, president of hartville hardware. how much of your sales have gone up? >> we've definitely seen an uptick in new home sales. recently i walked through the developments in my area where i live, and ten new homes are being built right now. one of our builders sold three houses last week. we're definitely seeing an uptick in building of new homes. >> what does that mean in terms of your sales? >> well, over the last several years, a lot of our builders from